PURPOSE: Photon therapy has been reported to induce resets of implanted cardiac devices, but the clinical sequelae of treating patients with such devices with proton beam therapy (PBT) are not well known. We reviewed the incidence of device malfunctions among patients undergoing PBT. METHODS AND MATERIALS: From March 2009 through July 2012, 42 patients with implanted cardiac implantable electronic devices (CIED; 28 pacemakers and 14 cardioverter-defibrillators) underwent 42 courses of PBT for thoracic (23, 55%), prostate (15, 36%), liver (3, 7%), or base of skull (1, 2%) tumors at a single institution. The median prescribed dose was 74 Gy (relative biological effectiveness; range 46.8-87.5 Gy), and the median distance from the treatment field to the CIED was 10 cm (range 0.8-40 cm). Maximum proton and neutron doses were estimated for each treatment course. All CIEDs were checked before radiation delivery and monitored throughout treatment. RESULTS: Median estimated peak proton and neutron doses to the CIED in all patients were 0.8 Gy (range 0.13-21 Gy) and 346 Sv (range 11-1100 mSv). Six CIED malfunctions occurred in 5 patients (2 pacemakers and 3 defibrillators). Five of these malfunctions were CIED resets, and 1 patient with a defibrillator (in a patient with a liver tumor) had an elective replacement indicator after therapy that was not influenced by radiation. The mean distance from the proton beam to the CIED among devices that reset was 7.0 cm (range 0.9-8 cm), and the mean maximum neutron dose was 655 mSv (range 330-1100 mSv). All resets occurred in patients receiving thoracic PBT and were corrected without clinical incident. The generator for the defibrillator with the elective replacement indicator message was replaced uneventfully after treatment. CONCLUSIONS: The incidence of CIED resets was about 20% among patients receiving PBT to the thorax. We recommend that PBT be avoided in pacing-dependent patients and that patients with any type of CIED receiving thoracic PBT be followed closely.
PURPOSE: Photon therapy has been reported to induce resets of implanted cardiac devices, but the clinical sequelae of treating patients with such devices with proton beam therapy (PBT) are not well known. We reviewed the incidence of device malfunctions among patients undergoing PBT. METHODS AND MATERIALS: From March 2009 through July 2012, 42 patients with implanted cardiac implantable electronic devices (CIED; 28 pacemakers and 14 cardioverter-defibrillators) underwent 42 courses of PBT for thoracic (23, 55%), prostate (15, 36%), liver (3, 7%), or base of skull (1, 2%) tumors at a single institution. The median prescribed dose was 74 Gy (relative biological effectiveness; range 46.8-87.5 Gy), and the median distance from the treatment field to the CIED was 10 cm (range 0.8-40 cm). Maximum proton and neutron doses were estimated for each treatment course. All CIEDs were checked before radiation delivery and monitored throughout treatment. RESULTS: Median estimated peak proton and neutron doses to the CIED in all patients were 0.8 Gy (range 0.13-21 Gy) and 346 Sv (range 11-1100 mSv). Six CIED malfunctions occurred in 5 patients (2 pacemakers and 3 defibrillators). Five of these malfunctions were CIED resets, and 1 patient with a defibrillator (in a patient with a liver tumor) had an elective replacement indicator after therapy that was not influenced by radiation. The mean distance from the proton beam to the CIED among devices that reset was 7.0 cm (range 0.9-8 cm), and the mean maximum neutron dose was 655 mSv (range 330-1100 mSv). All resets occurred in patients receiving thoracic PBT and were corrected without clinical incident. The generator for the defibrillator with the elective replacement indicator message was replaced uneventfully after treatment. CONCLUSIONS: The incidence of CIED resets was about 20% among patients receiving PBT to the thorax. We recommend that PBT be avoided in pacing-dependent patients and that patients with any type of CIED receiving thoracic PBT be followed closely.
Authors: Xin Wang; Narayan Sahoo; Ronald X Zhu; John R Zullo; Michael T Gillin Journal: Int J Radiat Oncol Biol Phys Date: 2010-01-25 Impact factor: 7.038
Authors: George H Crossley; Jeanne E Poole; Marc A Rozner; Samuel J Asirvatham; Alan Cheng; Mina K Chung; T Bruce Ferguson; John D Gallagher; Michael R Gold; Robert H Hoyt; Samuel Irefin; Fred M Kusumoto; Liza Prudente Moorman; Annemarie Thompson Journal: Heart Rhythm Date: 2011-07 Impact factor: 6.343
Authors: Suraj Kapa; Luis Fong; Charles R Blackwell; Michael G Herman; Paula J Schomberg; David L Hayes Journal: Pacing Clin Electrophysiol Date: 2008-06 Impact factor: 1.976
Authors: Vincenzo L Malavasi; Giuseppina De Marco; Jacopo F Imberti; Filippo Placentino; Marco Vitolo; Ercole Mazzeo; Gianfranco Cicoria; Edoardo Casali; Vincenzo Turco; Frank Lohr; Giuseppe Boriani Journal: Intern Emerg Med Date: 2019-12-02 Impact factor: 3.397
Authors: Daniel R Gomez; Syed Wamique Yusuf; Mark F Munsell; James W Welsh; Zhongxing Liao; Steven H Lin; Hubert Y Pan; Joe Y Chang; Ritsuko Komaki; James D Cox; Mary Frances McAleer; David R Grosshans Journal: J Thorac Oncol Date: 2014-10 Impact factor: 15.609
Authors: Amin Zagzoog; Matt Wronski; David H Birnie; Cynthia Yeung; Adrian Baranchuk; Jeffrey S Healey; Mehrdad Golian; Usama Boles; Aldo G Carrizo; Suzette Turner; Ahmed Hassan; Elsayed Ali; Sharath K Kumar; Steve Russell; Mohammed Shurrab; Eugene Crystal Journal: CJC Open Date: 2021-07-11
Authors: Katharina Seidensaal; Semi Ben Harrabi; Eberhard Scholz; Malte Ellerbrock; Thomas Haberer; Fabian Weykamp; Matthias Mattke; Stefan E Welte; Klaus Herfarth; Jürgen Debus; Matthias Uhl Journal: Front Oncol Date: 2019-08-22 Impact factor: 6.244